Competitive Drug Development International Limited in London, W2 5BU

Description

Data updated on: 01-11-2023

Competitive Drug Development International is a firm registered at W2 5BU London at 3 Courtnell Street. The enterprise was established in 2009 and is registered under reg. no. 06937090. The enterprise has been on the British market for fifteen years now and the status at the time is active. Started as Cddi, the firm used the name up till 2010-03-23, at which point it was replaced by Competitive Drug Development International Limited. The company's declared SIC number is 82990 - Other business support service activities not elsewhere classified. Competitive Drug Development International Ltd filed its account information for the period up to Sat, 31st Dec 2022. The business most recent annual confirmation statement was released on Sat, 17th Jun 2023.

At the moment, the directors enumerated by this specific limited company are as follow: Eva H. designated to this position in 2016 and Grahaem B. designated to this position 15 years ago.

Previous company's names
Competitive Drug Development International Limited 2010-03-23
Cddi Limited 2009-06-17

Financial data based on annual reports

Profit & Loss
Date of Accounts	2012-06-30	2013-06-30	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31
Currency	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP
Net Worth	78 094	65 361	86 772	105 305

Balance Sheet
Cash Bank In Hand	72 627	54 258	69 136	119 454
Cash Bank On Hand				119 454	36 128	100 770	196 849	344 933	128 367	180 025	351 136
Current Assets	164 277	169 844	353 995	243 858	175 341	177 873	414 087	361 309	244 620	307 569	446 248
Debtors	91 650	115 586	284 859	124 404	139 213	77 103	217 238	16 376	116 253	127 544	95 112
Net Assets Liabilities				105 305	62 042
Net Assets Liabilities Including Pension Asset Liability	78 094	65 361	86 772	105 305
Other Debtors				6 887	530	273	119 209	9 576	4 509	39 194	24 487
Property Plant Equipment				3 570	1 149	1 752	4 515	3 953	1 634	1 739	1 783
Tangible Fixed Assets	2 055	2 568	5 336	3 570

Capital & Reserves
Called Up Share Capital	150	150	500	275
Profit Loss Account Reserve	77 944	65 211	86 272	104 805
Shareholder Funds	78 094	65 361	86 772	105 305

Other Financial Data
Amount Specific Advance Or Credit Directors			3 339	2 820	1 249	14 327
Amount Specific Advance Or Credit Made In Period Directors				3 896	175	1 424
Amount Specific Advance Or Credit Repaid In Period Directors				3 377	1 424	14 502
Accrued Liabilities				9 728	91 628	15 948
Accumulated Depreciation Impairment Property Plant Equipment				8 120	10 541	12 240	14 929	12 537	15 474	17 315	18 704
Average Number Employees During Period					1	1	2	1	1	1	2
Capital Redemption Reserve				225
Corporation Tax Payable				90 684
Creditors				141 409	114 448	62 694	259 038	127 526	41 374	137 655	197 902
Creditors Due Within One Year	88 238	107 051	271 452	141 409
Increase From Depreciation Charge For Year Property Plant Equipment					2 421	1 699	2 689	3 333	2 937	1 841	1 389
Net Current Assets Liabilities	76 039	62 793	82 543	102 449	60 893	115 179	155 049	233 783	203 246	169 914	248 346
Number Shares Allotted	150	150	225	225
Other Creditors				9 403	2 125	43 107	227 157	113 080	26 389	123 647	160 316
Other Taxation Social Security Payable						5 926	7 236	9 576	9 910	6 123	8 625
Par Value Share	1	1	1	1
Prepayments Accrued Income				7 979	3 355	2 760
Property Plant Equipment Gross Cost				11 690	11 690	13 992	19 444	16 490	17 108	19 054	20 487
Provisions For Liabilities Balance Sheet Subtotal				714
Provisions For Liabilities Charges			1 107	714
Recoverable Value-added Tax				2 621	4 406	762
Share Capital Allotted Called Up Paid	150	150	225	50
Tangible Fixed Assets Additions		1 612	5 676	1 547
Tangible Fixed Assets Cost Or Valuation	2 855	4 467	10 143	11 690
Tangible Fixed Assets Depreciation	800	1 899	4 807	8 120
Tangible Fixed Assets Depreciation Charged In Period		1 099	2 908	3 313
Total Additions Including From Business Combinations Property Plant Equipment						2 302	5 452	4 862	618	1 946	1 433
Total Assets Less Current Liabilities	78 094	65 361	87 879	106 019	62 042	116 931	159 564	237 736	204 880	171 653	250 129
Trade Creditors Trade Payables				28 774	17 111	13 661	24 645	4 870	5 075	7 885	28 961
Trade Debtors Trade Receivables				106 917	130 922	73 308	98 029	6 800	111 744	88 350	70 625
Advances Credits Directors		1 063	898	2 820
Advances Credits Made In Period Directors			9 303
Advances Credits Repaid In Period Directors		1 063	12 089
Disposals Decrease In Depreciation Impairment Property Plant Equipment								5 725
Disposals Property Plant Equipment								7 816
Fixed Assets	2 055	2 568

Company staff

Eva H.

Role: Director

Appointed: 16 October 2016

Latest update: 3 January 2024

Executives who control the firm include: Eva H. owns 1/2 or less of company shares and has 1/2 or less of voting rights. Grahaem B. owns 1/2 or less of company shares and has 1/2 or less of voting rights.

Eva H.

Notified on 19 October 2016

Nature of control:

1/2 or less of voting rights

1/2 or less of shares

Grahaem B.

Notified on 6 April 2016

Nature of control:

1/2 or less of voting rights

1/2 or less of shares

Accounts Documents

Account next due date	30 September 2024
Account last made up date	31 December 2022
Confirmation statement next due date	01 July 2024
Confirmation statement last made up date	17 June 2023

Annual Accounts 24 January 2014
Start Date For Period Covered By Report	2012-07-01
End Date For Period Covered By Report	2013-06-30
Date Approval Accounts	24 January 2014
Annual Accounts 26 May 2015
Start Date For Period Covered By Report	01 July 2013
End Date For Period Covered By Report	31 December 2014
Date Approval Accounts	26 May 2015
Annual Accounts 9 September 2016
Start Date For Period Covered By Report	01 January 2015
End Date For Period Covered By Report	31 December 2015
Date Approval Accounts	9 September 2016
Annual Accounts
Start Date For Period Covered By Report	01 January 2016
End Date For Period Covered By Report	31 December 2016
Annual Accounts
Start Date For Period Covered By Report	01 January 2017
End Date For Period Covered By Report	31 December 2017
Annual Accounts
Start Date For Period Covered By Report	01 January 2018
End Date For Period Covered By Report	31 December 2018
Annual Accounts
Start Date For Period Covered By Report	01 January 2019
End Date For Period Covered By Report	31 December 2019
Annual Accounts
Start Date For Period Covered By Report	01 January 2020
End Date For Period Covered By Report	31 December 2020
Annual Accounts
Start Date For Period Covered By Report	01 January 2021
End Date For Period Covered By Report	31 December 2021
Annual Accounts
Start Date For Period Covered By Report	01 January 2022
End Date For Period Covered By Report	31 December 2022

Competitive Drug Development International Limited

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Eva H.

Grahaem B.

Bernard C.

Elizabeth R.

Gyongyi S.

Michael T.

People with significant control

Eva H.

Grahaem B.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Similar companies nearby

Closest companies